TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  GlobeNewswire Inc.

JSPR DEADLINE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Jasper Therapeutics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – JSPR

GlobeNewswire Inc. Logo GlobeNewswire Inc. By Rosen Law Firm
JSPR DEADLINE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Jasper Therapeutics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – JSPR

Rosen Law Firm is pursuing a securities class action lawsuit against Therapeutics for allegedly making false and misleading statements about manufacturing controls and product prospects during the period of November 30, 2023 to July 3, 2025.

Insights
JSPR   negative

The lawsuit alleges the company made false statements about manufacturing procedures, regulatory compliance, and overstated business prospects, which potentially misled investors and caused financial damages